Lam Research Corporation $LRCX Shares Purchased by Carderock Capital Management Inc.

Carderock Capital Management Inc. grew its position in Lam Research Corporation (NASDAQ:LRCX) by 2.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 121,370 shares of the semiconductor company’s stock after purchasing an additional 3,127 shares during the period. Lam Research makes up approximately 4.0% of Carderock Capital Management Inc.’s holdings, making the stock its 2nd biggest position. Carderock Capital Management Inc.’s holdings in Lam Research were worth $16,251,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in LRCX. IMG Wealth Management Inc. bought a new position in Lam Research in the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research during the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research during the 2nd quarter worth $29,000. Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the second quarter worth $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research during the second quarter valued at $31,000. Institutional investors own 84.61% of the company’s stock.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is currently owned by company insiders.

Lam Research Stock Up 0.4%

LRCX stock opened at $178.07 on Monday. The firm has a market cap of $223.66 billion, a PE ratio of 39.22, a P/E/G ratio of 2.06 and a beta of 1.77. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $179.80. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The firm has a 50 day simple moving average of $158.39 and a 200 day simple moving average of $126.45.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the previous year, the business posted $0.86 earnings per share. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s payout ratio is 22.91%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on LRCX shares. HSBC set a $127.00 price objective on shares of Lam Research and gave the stock a “hold” rating in a report on Tuesday, September 30th. Citigroup boosted their price target on shares of Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research report on Tuesday, November 11th. The Goldman Sachs Group increased their price objective on shares of Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. Cowen reiterated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday, December 22nd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $161.21.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.